120 related articles for article (PubMed ID: 17261498)
1. Establishment of an arsenic trioxide-resistant human leukemia cell line that shows multidrug resistance.
Seo T; Urasaki Y; Ueda T
Int J Hematol; 2007 Jan; 85(1):26-31. PubMed ID: 17261498
[TBL] [Abstract][Full Text] [Related]
2. Differential expression and response to arsenic stress of MRPs and ASAN1 determine sensitivity of classical multidrug-resistant leukemia cells to arsenic trioxide.
Chen J; Cheng J; Yi J; Xie B; Lin L; Liu Z; Zhao H; Wang B; Ai Z; Yang Y; Wei H
Leuk Res; 2016 Nov; 50():116-122. PubMed ID: 27736728
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide circumvents multidrug resistance based on different mechanisms in human leukemia cell lines.
Seo T; Urasaki Y; Takemura H; Ueda T
Anticancer Res; 2005; 25(2A):991-8. PubMed ID: 15868938
[TBL] [Abstract][Full Text] [Related]
4. Resistance of human multidrug resistance-associated protein 1-overexpressing lung tumor cells to the anticancer drug arsenic trioxide.
Vernhet L; Allain N; Payen L; Anger JP; Guillouzo A; Fardel O
Biochem Pharmacol; 2001 Jun; 61(11):1387-91. PubMed ID: 11331074
[TBL] [Abstract][Full Text] [Related]
5. [Arsenic trioxide combined with buthionine sulfoximine enhances apoptosis in multidrug-resistant human leukemia K562/ADM cells in vitro].
Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):188-91. PubMed ID: 18756933
[TBL] [Abstract][Full Text] [Related]
6. [Effect of arsenic trioxide on drug transporting molecules in acute promyelocytic leukemia cell line].
Qian XP; Liu BR; Yin HT; Wang LF; Zou ZY; Du J
Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):601-5. PubMed ID: 15634520
[TBL] [Abstract][Full Text] [Related]
7. Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells.
Tabellini G; Cappellini A; Tazzari PL; Falà F; Billi AM; Manzoli L; Cocco L; Martelli AM
J Cell Physiol; 2005 Feb; 202(2):623-34. PubMed ID: 15316930
[TBL] [Abstract][Full Text] [Related]
8. [The effect of arsenic trioxide (As2O3) combined with BSO on K562/ADM cell and its mechanisms].
Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):438-43. PubMed ID: 18072624
[TBL] [Abstract][Full Text] [Related]
9. Effects of arsenic trioxide (As2O3) on leukemic cells from patients with non-M3 acute myelogenous leukemia: studies of cytotoxicity, apoptosis and the pattern of resistance.
Lehmann S; Bengtzen S; Paul A; Christensson B; Paul C
Eur J Haematol; 2001 Jun; 66(6):357-64. PubMed ID: 11488934
[TBL] [Abstract][Full Text] [Related]
10. [Arsenic trioxide inhibits P-glycoprotein expression in multidrug-resistant human leukemia K562/ADM cell line that overexpresses mdr-1 gene and enhances their chemotherapeutic sensitivity].
Wei HL; Yao XJ; Li YN; Wang P; Zhao HS; Bai DC; Peng X; Ma LF
Zhonghua Xue Ye Xue Za Zhi; 2003 Jan; 24(1):28-31. PubMed ID: 12679007
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 and omega-6 polyunsaturated fatty acids enhance arsenic trioxide efficacy in arsenic trioxide-resistant leukemic and solid tumor cells.
Wirtitsch M; Roth E; Bachleitner-Hofmann T; Wessner B; Sturlan S
Oncol Res; 2009; 18(2-3):83-94. PubMed ID: 20066898
[TBL] [Abstract][Full Text] [Related]
12. Low dose of arsenic trioxide inhibits multidrug resistant-related P-glycoprotein expression in human neuroblastoma cell line.
Liu L; Li Y; Xiong X; Qi K; Zhang C; Fang J; Guo H
Int J Oncol; 2016 Dec; 49(6):2319-2330. PubMed ID: 27840903
[TBL] [Abstract][Full Text] [Related]
13. Blockage of multidrug resistance-associated proteins potentiates the inhibitory effects of arsenic trioxide on CYP1A1 induction by polycyclic aromatic hydrocarbons.
Vernhet L; Allain N; Le Vée M; Morel F; Guillouzo A; Fardel O
J Pharmacol Exp Ther; 2003 Jan; 304(1):145-55. PubMed ID: 12490585
[TBL] [Abstract][Full Text] [Related]
14. The overexpression of multidrug resistance-associated proteins and gankyrin contribute to arsenic trioxide resistance in liver and gastric cancer cells.
Chen X; Zhang M; Liu LX
Oncol Rep; 2009 Jul; 22(1):73-80. PubMed ID: 19513507
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the mechanism involved in the As2O3-regulated decrease in MDR1 expression in leukemia cells.
Gao F; Liu J; Dong WW; Wang W; Wang Y; Cai D; Zheng Z; Sun K
Oncol Rep; 2014 Feb; 31(2):926-32. PubMed ID: 24337533
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of P-gp, Ras and p-ERK1/2 contributes to the arsenic trioxide-induced reduction in drug resistance towards doxorubicin in gastric cancer cell lines.
Zhao YY; Yu L; Liu BL; He XJ; Zhang BY
Mol Med Rep; 2015 Nov; 12(5):7335-43. PubMed ID: 26459009
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of nuclear matrix proteins during arsenic trioxide induced apoptosis in leukemia K562 cells.
Wang ZH; Yu D; Chen Y; Hao JZ
Chin Med J (Engl); 2005 Jan; 118(2):100-4. PubMed ID: 15667793
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a daunorubicin-resistant cell line which shows multi-drug resistance by multifactorial mechanisms.
Urasaki Y; Ueda T; Yoshida A; Fukushima T; Takeuchi N; Tsuruo T; Nakamura T
Anticancer Res; 1996; 16(2):709-14. PubMed ID: 8687117
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells.
Yang CH; Kuo ML; Chen JC; Chen YC
Br J Cancer; 1999 Nov; 81(5):796-9. PubMed ID: 10555748
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of arsenic trioxide-mediated apoptosis using docosahexaenoic acid in arsenic trioxide-resistant solid tumor cells.
Baumgartner M; Sturlan S; Roth E; Wessner B; Bachleitner-Hofmann T
Int J Cancer; 2004 Nov; 112(4):707-12. PubMed ID: 15382055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
